Model | Term | Group | N | Mortality rate, N (%) | HR (95% CI) | SHR (95% CI) | |
---|---|---|---|---|---|---|---|
 |  |  |  | All-cause | CVD-related | All-cause | CVD-related |
1 | 33-FI | Continuous | 18,095 | 1,820 (7.7%) | 554 (2.1%) | 1.04 (1.03,1.04) | 1.02 (1.02,1.03) |
 | LS7 | Continuous | 18,095 | 1,820 (7.7%) | 554 (2.1%) | 0.95 (0.92,0.98) | 0.91 (0.87,0.95) |
2 | 33-FI | 0.0–0.1 | 10,814 | 421 (2.9%) | 100 (0.6%) | Reference | |
 |  | 0.1–0.2 | 4115 | 491 (10.3%) | 153 (3.0%) | 1.49 (1.29,1.72) | 1.47 (1.13,1.91) |
 |  | 0.2–0.3 | 1,641 | 392 (21.6%) | 130 (6.3%) | 2.25 (1.87,2.70) | 1.92 (1.45,2.56) |
 |  | 0.3< | 1,525 | 516 (31.7%) | 171 (9.6%) | 3.52 (2.94,4.21) | 2.52 (1.91,3.32) |
 | LS7 | 3rd tertile | 4,860 | 162 (2.2%) | 40 (0.5%) | Reference | |
 |  | 2nd tertile | 5,577 | 475 (7.0%) | 118 (1.6%) | 1.40 (1.11,1.77) | 0.94 (0.66,1.35) |
 |  | 1st tertile | 7,658 | 1,183 (12.7%) | 396 (3.8%) | 1.52 (1.21,1.89) | 1.43 (1.02,2.01) |
3 | 40-FI | Continuous | 18,095 | 1,820 (7.7%) | 554 (2.1%) | 1.05 (1.04,1.05) | 1.04 (1.03,1.04) |
4 | 40-FI | 0.0–0.1 | 5,420 | 111 (1.4%) | 21 (0.2%) | Reference | |
 |  | 0.1–0.2 | 7,593 | 503 (5.4%) | 138 (1.4%) | 1.54 (1.12,2.12) | 1.45 (0.90,2.31) |
 |  | 0.2–0.3 | 2,921 | 513 (15.7%) | 166 (4.7%) | 2.43 (1.76,3.35) | 2.12 (1.31,3.45) |
 |  | 0.3< | 2,161 | 693 (29.9%) | 229 (8.9%) | 4.62 (3.24,6.59) | 3.25 (2.00,5.27) |